Found 7 matching trials
SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study
PHASE4After endovascular treatment (EVT) for peripheral artery disease (PAD), dua...
Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions
PHASE1A Single-dose, Comparative Bioavailability Study of Two Formulations of Sar...
Location
Daewoong pharmatceutical
A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions
PHASE1A Single-dose, Comparative Bioavailability Study of Two Formulations of Sar...
Location
Deawoong pharmaceutical
A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions
PHASE1A Single-dose, Comparative Bioavailability Study of Two Formulations of Sar...
Location
Daewoong pharmatceutical
Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease
PHASE4This clinical trial aims to assess the non-inferiority of Sarpogrelate SR 3...
Location
GangNeung Asan Hospital
Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease
PHASE3Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, has been widely ...
Location
Multiple Locations
Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions
PHASE1A Single-dose, Comparative Bioavailability Study of Two Formulations of Sar...
Location
Daewoong pharmatceutical